Not applicableStudy completedNCT00900302What this trial is testingOX-40 Protein Expression in the Sentinel Lymph Nodes of Patients With CancerWho this might be right forCancer OHSU Knight Cancer Institute 98
Testing effectiveness (Phase 2)Ended earlyNCT01855724What this trial is testingClinical Trial to Investigate the Efficacy of Treatment With Gemcitabine/Pazopanib in Patients With Biliary Tree CancerWho this might be right forCholangiocarcinomaGallbladder CarcinomaBiliary Carcinoma Hellenic Cooperative Oncology Group 29
Testing effectiveness (Phase 2)Study completedNCT00107536What this trial is testingLapatinib Ditosylate in Treating Patients With Unresectable Liver or Biliary Tract CancerWho this might be right forAdult Primary Hepatocellular CarcinomaAdvanced Adult Primary Liver CancerLocalized Unresectable Adult Primary Liver Cancer+5 more National Cancer Institute (NCI) 26
Early research (Phase 1)Study completedNCT04164069What this trial is testingDasatinib for the Prevention of Oxaliplatin-Induced Neuropathy in Patients With Metastatic Gastrointestinal Cancer Receiving FOLFOX Chemotherapy With or Without BevacizumabWho this might be right forAdvanced Colorectal CarcinomaMetastatic Colorectal CarcinomaStage IV Colorectal Cancer AJCC v8+13 more Anne Noonan 9
Testing effectiveness (Phase 2)Ended earlyNCT05009953What this trial is testingStudy of Irinotecan Liposome Injection in Patients With Advanced Biliary Tract CancerWho this might be right forAdvanced Biliary Tract CancerIntrahepatic CholangiocarcinomaExtrahepatic Cholangiocarcinoma+1 more CSPC Ouyi Pharmaceutical Co., Ltd. 17
Not applicableLooking for participantsNCT04907643What this trial is testingVirtual Reality for GI Cancer Pain to Improve Patient Reported OutcomesWho this might be right forCancer PainVisceral PainGastrointestinal Neoplasms+76 more Cedars-Sinai Medical Center 360
Testing effectiveness (Phase 2)Study completedNCT00003276What this trial is testingIrinotecan in Treating Patients With Advanced Gallbladder or Bile Duct CancerWho this might be right forGallbladder Cancer Alliance for Clinical Trials in Oncology 40
Testing effectiveness (Phase 2)Enrolling By InvitationNCT07310069What this trial is testingGemcitabine and Nab-Paclitaxel Combined With Iparomlimab and Tuvorilimab for Advanced Gallbladder CancerWho this might be right forGallbladder Cancer Unresectable Xinhua Hospital, Shanghai Jiao Tong University School of Medicine 44
Testing effectiveness (Phase 2)UnknownNCT06013943What this trial is testingEnvafolimab Combined With GEMOX in First-line Treatment of Advanced GBCWho this might be right forGallbladder Cancer Eastern Hepatobiliary Surgery Hospital 30
Testing effectiveness (Phase 2)WithdrawnNCT02720601What this trial is testingIrinotecan and Capecitabine as Second-line Treatment for Advanced/Metastatic Biliary Tract CancersWho this might be right forBiliary Tract Cancer New Mexico Cancer Research Alliance
Early research (Phase 1)Study completedNCT00020579What this trial is testingMS-275 in Treating Patients With Advanced Solid Tumors or LymphomaWho this might be right forCancer National Institutes of Health Clinical Center (CC) 75
Testing effectiveness (Phase 2)Study completedNCT05253053What this trial is testingTo Evaluate Efficacy and Safety of TT-00420 (Tinengotinib) as Monotherapy and Combination Therapy in Patients With Advanced Solid TumorsWho this might be right forAdvanced Solid TumorCholangiocarcinomaBiliary Tract Cancer+8 more TransThera Sciences (Nanjing), Inc. 84
Large-scale testing (Phase 3)Not Yet RecruitingNCT07765433What this trial is testingTesting the Addition of Ivonescimab Combined With Standard Chemotherapy Compared to the Usual Chemotherapy and Immunotherapy Treatment for Patients With Advanced Biliary Tract CancerWho this might be right forLocally Advanced Biliary Tract AdenocarcinomaLocally Advanced Extrahepatic CholangiocarcinomaLocally Advanced Intrahepatic Cholangiocarcinoma+12 more ECOG-ACRIN Cancer Research Group
Early research (Phase 1)Study completedNCT00031681What this trial is testing7-Hydroxystaurosporine and Irinotecan Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors or Triple Negative Breast Cancer (Currently Accruing Only Triple-negative Breast Cancer Patients Since 6/8/2007)Who this might be right forAdvanced Adult Primary Liver CancerCarcinoma of the AppendixEstrogen Receptor-negative Breast Cancer+85 more National Cancer Institute (NCI) 41
Post-approval studies (Phase 4)UnknownNCT00274885What this trial is testingRelationship Between Platinum Levels in the Blood and Neurotoxicity in Patients Who Are Receiving Oxaliplatin for Gastrointestinal CancerWho this might be right forCancer GERCOR - Multidisciplinary Oncology Cooperative Group 58
Testing effectiveness (Phase 2)Study completedNCT00096083What this trial is testingHepatic Arterial Infusion of Melphalan With Hepatic Perfusion in Treating Patients With Unresectable Liver CancerWho this might be right forCancer Delcath Systems Inc. 56
Testing effectiveness (Phase 2)Ended earlyNCT01151761What this trial is testingPhase II SBRT & Chemo for Unresectable Cholangiocarcinoma Followed by Liver TransplantationWho this might be right forCholangiocarcinomaHepatobiliary NeoplasmLiver Cancer+2 more Stanford University 2
Testing effectiveness (Phase 2)WithdrawnNCT01859182What this trial is testingSelumetinib and Akt Inhibitor MK-2206 in Treating Patients With Refractory or Advanced Gallbladder or Bile Duct Cancer That Cannot Be Removed By SurgeryWho this might be right forAdenocarcinoma of the GallbladderAdenocarcinoma With Squamous Metaplasia of the GallbladderAdult Primary Cholangiocellular Carcinoma+12 more National Cancer Institute (NCI)
Testing effectiveness (Phase 2)Study completedNCT00059865What this trial is testingGemcitabine Plus Pemetrexed Disodium in Treating Patients With Unresectable or Metastatic Biliary Tract or Gallbladder CancerWho this might be right forExtrahepatic Bile Duct CancerGallbladder CancerLiver Cancer Alliance for Clinical Trials in Oncology 68
Testing effectiveness (Phase 2)WithdrawnNCT04931420What this trial is testingStudy Comparing Standard of Care Chemotherapy With/ Without Sequential Cytoreductive Surgery for Patients With Metastatic Foregut Cancer and Undetectable Circulating Tumor-Deoxyribose Nucleic Acid LevelsWho this might be right forMetastatic CancerForegut Carcinoid TumorGastric Adenocarcinoma+5 more University of Chicago